Ray Dalio
ALKS icon

Ray Dalio’s Alkermes ALKS Stock Holding History

Ray Dalio’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.96M Sell
83,806
-260,646
-76% -$8.09M 0.01% 557
2025
Q4 		$9.64M Buy
+344,452
New +$10.3M 0.04% 366
2024
Q2 		– Sell
-7,400
Closed -$200K – 880
2024
Q1 		$200K Sell
7,400
-33,584
-82% -$954K ﹤0.01% 674
2023
Q4 		$1.14M Buy
40,984
+8,083
+25% +$210K 0.01% 619
2023
Q3 		$922K Sell
32,901
-1,367
-4% -$40.1K 0.01% 622
2023
Q2 		$1.07M Sell
34,268
-223
-0.6% -$6.75K 0.01% 564
2023
Q1 		$972K Sell
34,491
-6,046
-15% -$165K 0.01% 566
2022
Q4 		$1.06M Buy
40,537
+12,311
+44% +$295K 0.01% 636
2022
Q3 		$630K Sell
28,226
-1,427
-5% -$37.1K ﹤0.01% 755
2022
Q2 		$883K Buy
29,653
+2,041
+7% +$58.6K ﹤0.01% 806
2022
Q1 		$726K Buy
27,612
+8,280
+43% +$205K ﹤0.01% 840
2021
Q4 		$450K Buy
19,332
+2,449
+15% +$64.4K ﹤0.01% 654
2021
Q3 		$521K Buy
16,883
+589
+4% +$16.6K ﹤0.01% 590
2021
Q2 		$400K Buy
+16,294
New +$362K ﹤0.01% 667

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Ray Dalio's ALKS Position: Q1 2026 in Review

Ray Dalio reduced its Alkermes (ALKS) stake by 76% in Q1 2026, selling an estimated $8.09M and leaving 83,806 shares worth $2.96M. The position accounts for 0.01% of the portfolio, ranked #557.

Ray Dalio first reported a position in ALKS in Q2 2021 and has held it in 14 quarters since. The position peaked at $9.64M in Q4 2025. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Ray Dalio held 83,806 shares of Alkermes worth $2.96M as of Q1 2026.
  • Ray Dalio sold 260,646 Alkermes shares in Q1 2026, an estimated $8.09M.
  • Alkermes made up 0.01% of Ray Dalio's portfolio in Q1 2026, its #557 holding.
  • Ray Dalio first reported a position in Alkermes in Q2 2021 and has held it in 14 quarters since.
  • Ray Dalio's Alkermes position peaked at $9.64M in Q4 2025.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.